Development of Clinical Database of Individuals With Smith-Magenis Syndrome and Sleep Disturbances

Study Summary

This database will be used to better understand the sleep problems of people with SMS. This clinical database will be a part of a larger Smith-Magenis Patient Registry used to create an awareness campaign around SMS and the sleep disturbances that are characteristic of the disorder.

Conditions

Sleep Disturbances in Smith-Magenis Syndrome

Interventions / Drugs

Data collection of sleep disturbances in individuals with SMS

View on ClinicalTrials.gov ↗

Sponsor

VNDA

Vanda Pharmaceuticals

Neuroscience

D38/100

Study Details

Enrollment1000 participants

Primary Completion—

Lead SponsorVanda Pharmaceuticals

Data Retrieved2026-04-11 04:31:05.188650+00:00

Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.